Live Breaking News & Updates on Oral Health Study

Stay updated with breaking news from Oral health study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New substance suppresses the growth of harmful bacteria that cause periodontitis


New substance suppresses the growth of harmful bacteria that cause periodontitis
Targeted, efficient and with few side effects: A new method for combating periodontitis could render the use of broad-spectrum antibiotics superfluous. It was developed and tested for the first time by a team from Martin Luther University Halle-Wittenberg (MLU), the Fraunhofer Institute for Cell Therapy and Immunology IZI and Periotrap Pharmaceuticals GmbH. The aim is to neutralize only bacteria that cause periodontitis while sparing harmless bacteria. The study appeared in the
Journal of Biological Chemistry.
Periodontitis is a common bacterial inflammation of the gums. According to the World Health Organization WHO Oral Health Study, almost 10 percent of the global population are affected with a severe form of the disease, which can lead to tooth loss as well as increasing the risk of other diseases, such as Alzheimer s and cardiovascular disease. Until now, treatment has mainly involve ....

Miltont Stubbs , Mirko Buchholz , Emily Henderson , Periotrap Pharmaceuticals Gmb , Martin Luther University Halle Wittenberg , Jagiellonian University In Krakow , World Health Organization , Periotrap Pharmaceuticals , Fraunhofer Institute For Cell Therapy , University Of Bern , Department Of Drug Design , Oral Health Study , University Of Louisville , Fraunhofer Institute , Cell Therapy , Health Study , Professor Milton , Drug Design , Target Validation , Dental Medicine , Jagiellonian University , United States , மிற்கோ புச்சோல்ஸ் , எமிலி ஹென்டர்சன் , மார்டின் லூதர் பல்கலைக்கழகம் ஹால் விட்டன்பெர்க் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் ,

Periodontitis: Researchers search for a new active substance

Targeted, efficient and with few side effects: A new method for combating periodontitis could render the use of broad-spectrum antibiotics superfluous. It was developed and tested for the first time by a team from Martin Luther University Halle-Wittenberg (MLU), the Fraunhofer Institute for Cell Therapy and Immunology IZI and Periotrap Pharmaceuticals GmbH. The aim is to neutralise only bacteria that cause periodontitis while sparing harmless bacteria. The study appeared in the ....

Miltont Stubbs , Mirko Buchholz , Periotrap Pharmaceuticals Gmb , Martin Luther University Halle Wittenberg , Jagiellonian University In Krakow , World Health Organization , Periotrap Pharmaceuticals , Fraunhofer Institute For Cell Therapy , University Of Bern , Department Of Drug Design , Oral Health Study , University Of Louisville , Fraunhofer Institute , Cell Therapy , Health Study , Professor Milton , Drug Design , Target Validation , Dental Medicine , Jagiellonian University , United States , Biological Chemistry , Chemistry Physics Materials Sciences , Medicine Health , Dentistry Periodontal Disease , மிற்கோ புச்சோல்ஸ் ,